Crystec

Crystec Pharma is based on the characteristics of supercritical fluid crystallization and applies this technology to inhalation drug delivery, particularly in high-end generic and innovative generic drugs. As a principled innovation technology, supercritical crystallization improves drug delivery effectiveness and in vivo absorption by adjusting the physical properties of drugs. Therefore, this technology has a wide range of applications, including the following aspects: polymorph screening, solubility enhancement of poorly soluble drugs, stability of active pharmaceutical ingredients (APIs), cocrystals and polymer composite formulations, and the development and application of solid formulations for biologics.